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Abstract
The permuted myoglobin HGL16 is known to be structurally and functionally 
similar to the wild-type (wt) sperm whale myoglobin (swMb) yet is less stable to 
chemical denaturation by 5.2 kcal/mole. Given published reports that stabilities of 
myoglobin mutants are correlated to expression yields and our own confirmation of this 
correlation, we are eager to increase expression yields of our destabilized permutants to 
facilitate protein characterization. One method, fusing HGL16 to Maltose-Binding 
Protein (MBP), increases yields but appears to destabilize the fused HGL16. Another 
method for increasing yields, overexpressing protein in the form of inclusion bodies, is 
particularly useful as it yields apo-myoglobin (apoMb), necessary for investigating true 
two-state unfolding and the apoMb pH 4.2 intermediate. Urea denaturation studies show 
our methods of purification are valid, but pH denaturations of our directly expressed, 
purified apo wt myoglobin remain inconclusive. Further, mutating the distal histidine to 
phenylalanine (H64F) has been shown to increase the stability of wt swMb, at the cost of 
impaired function. Introducing an H64F mutation into the HGL16 permutein results in 
soluble protein with similar expression yields to HGL16 but with a shifted heme 
absorbance. Preliminary characterization studies yield a reproducible and non- 
cooperative denaturation curve for holo-H64F-HGL16.
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Increasing Expression Yields of Circularly-Permuted Myoglobins
Background:
Sperm whale myoglobin, our research group’s model protein, functions as an 
oxygen-binding protein. While similar to the four subunits of hemoglobin, myoglobin 
binds oxygen more tightly than hemoglobin; myoglobin is found in large concentrations 
in muscle tissue, where oxygen is needed for muscle function. As the partial pressure of 
oxygen falls during aerobic exercise, myoglobin begins to release its bound oxygen, 
modulating the decrease.
As a model system, myoglobin is excellent. It is small (153 amino acids), like 
other globin proteins. When the heme group—which binds oxygen—is removed, 
myoglobin shows prototypical two-state unfolding, making calculations of free energy 
simple. As an all-alpha helical protein, myoglobin is easily monitored by circular 
dichroism spectroscopy (CD), providing a clear, native-protein method for monitoring 
changes in secondary structure. On account of the heme group, myoglobin is red in color, 
and can be qualitatively visualized in a heterogeneous protein pool or quantitatively by 
the heme’s characteristic, native-protein absorbance at 418 nm (the Soret absorbance).
Myoglobin was the first protein to have its three-dimensional structure solved, in 
1961 by John Kendrew and associates; since then, many mutants of myoglobin, with 
many states of the heme (cyano, met, aquo, etc.), have been characterized. Typically, a 
researcher would avoid such a canonical protein in the search for novel protein structures. 
However, for our work, circular permutation of sperm whale myoglobin (see 
introduction for specifics), the extensive characterization of myoglobin is our foundation. 
We want to learn what happens when a large region of the primary structure of
Casey Kulla, 1
Increasing Expression Yields of Circularly-Permuted Myoglobins
myoglobin is moved around in the protein—for this, we must compare our novel forms to 
the native structure.
Introduction:
Methods for increasing expression yields will be essential in the development of 
engineered proteins as drug therapeutics and diagnostics, as well as industrial process 
catalysts. It is likely that increasing yields will not be simply a matter of increasing the 
stability of the folded protein—due to the need to balance protein stability and function. 
Chemical and thermal stability are not always correlated with desired protein activity (1). 
To increase yields, protein chemists must understand the processes underlying stability, 
solubility, and folding pathways of proteins.
The function, stability, folding pathway and denaturant-stabilized intermediates of 
sperm whale myoglobin (swMb) have been extensively characterized (2,4, 5, 11-17). 
Apomyoglobins of swMb—apo is the protein without the heme ligand, while 
holomyoglobin contains the heme—have been studied most closely due to the more truly 
two-state unfolding and folding of apoMb compared to holoMb (2, 11-14. 16). Point 
mutations may give clues to the local environments of amino acid residues in folded 
swMb, but more information is needed to address larger issues such as how an entire 
region is structured in folding intermediates such as the molten globule (MG). The MG is 
a pH-stabilized intermediate in apoMb believed to be on the folding pathway from 
unfolded to folded, native myoglobin—the molten globule contains much of the 
secondary structure of the native state but few of the specific tertiary contacts found in 
the native structure of apoMb (2).
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We want to probe the question of how, during folding, an entire region of a 
protein may undergo structural change. A topological mutation, such as physically 
linking the A and H helices of swMb, can be used to answer this question of what may be 
necessary for globin protein folding. Circular permutation is one method of changing 
topology in a protein. This method involves linking the N- and C-termini of the protein
Figure 1. In circular permutation, the original N- and C-termini are connected by a 
linker and new N- and C-termini are created within the protein. This changes the 
arrangement of the secondary structural elements, which are shown as rectangles in this 
diagram.
with an unstructured peptide linker and creating new N- and C-termini between any two 
amino acids in the protein (Figure 1). Circularly-permuted proteins are known as circular 
permuteins. Circular permutation is useful for probing how primary sequence and 
functional tertiary structure are related, and Iwakura et al. 2000 have shown that new 
termini can be inserted nearly anywhere in a model protein by systematically permuting 
each residue—creating as many permuteins as there are residues in the protein (3).
With eight alpha helices, A-H, swMb is a good candidate for circular 
permutation, as one helix at a time could be moved to the N-terminus of the protein. A
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circular permutein of swMb (Figure 2), where the native N- and C-temiini are spanned by 
a 16 residue linker (SGGG)4, and new termini are created in the loop between the G and 
H helices (Pro 120 is the new C-terminus and Gly 121 is the new N-terminus), has been 
reported recently (4). This new circular permutein, “HGL16,” was shown to be similar in 
ligand binding and folded structure to wt swMb, though thermodynamically destablized 
by 5.2 kcal/mol.
16 aa Linker
Fit- lUI
Figure 2: Schematic drawing of the eight alpha helices in swMb, with the 
HGL16 permutein below.
The gene encoding swMb has been optimized for expression in bacteria (15), but 
low expression yields plague the HGL16 permutein, corroborating an observation that 
destabilizing mutants of swMb show decreased yields relative to wt (5). Further 
characterization of HGL16, including NMR structure solution (which requires up to 30 
mg of protein), stopped-flow experiments, and apoprotein folding experiments, 
necessitates increasing the expression yield of recombinant protein. Additionally, studies 
of HGL16 require that current researchers purify liter upon liter of cell culture before any 
characterization can begin, greatly slowing the pace of experimentation.
We explored three methods for increased expression of HGL16 permuted 
myoglobins: (1) a fusion protein system involving Maltose-Binding Protein (MBP), (2)
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apo-protein expression using a modified inclusion body protocol, and (3) a stabilizing 
point mutation, H64F. Together, these methods probe issues of solubility, stability, and 
partnered promotion: is there more than increased stability to increased expression of 
engineered proteins?
Protein fusion systems have been used extensively to increase expression, 
stability, solubility, and ease purification of target proteins. It is postulated that a highly- 
expressing protein, when fused to a target protein, promotes expression of the target by 
stabilizing it and slowing in vivo proteolytic degradation. MBP is a popular fusion 
partner (6-10), used, for example, in high throughput proteomics for expressing human 
proteins of unknown structure and function. Ideally, the target protein is cleaved from 
MBP in the purification process, allowing for characterization solely of the target. We 
explore whether fusing MBP to HGL16 increases expression of HGL16; we do this by 
fusing them, performing expression studies and optimizing cleavage of the fusion protein. 
We also looked at the effect of MBP fusion on the stability of HGL16 by denaturing the 
fusion protein.
The high-level overexpression of apoMb in E. coli leads to aggregation of the 
protein into insoluble “inclusion bodies.” Continuing this overexpression can make target 
protein comprise up to 50% of total cellular protein. As bacteria do not make heme at the 
rate of apomyoglobin production, the inclusion bodies contain nearly pure apo-protein; as 
well, aggregates do not have a heme binding pocket. This is crucial for our lab, given the 
already low yields of holo-HGL16. Extracting the heme requires unfolding the protein— 
upon refolding, 80% of the starting HGLI6 is lost through aggregation. Apomyoglobin 
is desirable as mentioned above because it represents more closely a true two-state
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system; most swMb studies of folding are therefore performed with apoMb (e.g., the pH 
4.2 apoMb intermediate has been extensively characterized: 11-14). As HGL16 must be 
compared to wt, the increased and direct production of apo-HGL16 is crucial to our 
understanding of how topological mutations affect folding pathways.
Stabilizing point mutations in wt swMb have been reported (13). Mutating the 
distal histidine (H64, E helix) to phenylalanine causes the protein to gain stability through 
the hydrophobic effect and the reduction in solvated surface area. Some loss of function 
is seen with this mutation, as H64 coordinates the binding of oxygen and discriminates 
against carbon monoxide (16); however, there is an observed increase in stability ot 
unfolding, AAG°h20= + 2.8 kcal/mol for apo-H64F vs. wt swMb, with a change in Cm of 
1.0 M urea. AG°h2o is a measure of protein stability (change in Gibbs free energy 
between unfolded and native protein states, with no denaturant present, at 25° C and IM 
protein concentration), and AAG°h2o= AG°H2o(mut)- AG°H2o(wt). Cm is the 
concentration of denaturant at the midpoint of the transition; the larger Cm, the greater the 
resistance of the protein to denaturation— Cm is a more qualitative measure of protein 
stability than AG°h20. With such a large increase in the free energy of unfolding 
compared to wt protein, we reasoned that H64F may increase the stability—and therefore 
yields—of the HGL16 permuted myoglobin. It should be noted that the numbering of 
amino acid residues is based upon the wt sequence, not the permuted sequence. Data 
suggest that the folding pathway, folding kinetics, and the MG state of H64F apo-Mb are 
significantly changed from those of the wt swMb (13). Comparing the stability and 
structure of H64F-HGL16 to HGL16, H64F-wt swMb, and wt swMb may give us
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insights into how point mutations affect topological mutants, and specifically how 
HGL16 differs from wt in and around the E helix and heme pocket.
The three methods for increasing expression yields of permuted myoglobins will 
do more than give us more protein; each can tell us—as we characterize the protein 
produced—about the stability, electrostatic and hydrophobic environments, folding 
pathway and intermediates, and function of our permuted HGL16.
Materials and Methods
All enzymes were purchased from New England Biolabs (NEB)
Sperm Whale Myoglobin Gene:
The myoglobin gene we are using has been optimized for expression in E. coli 
(15). The synthetic approach which was used to generate the recombinant gene allowed 
for the incorporation of codons with optimum usage bias, a Shine-Dalgamo sequence and 
spacer region from the Pseudomonas putida cytochrome P-450cam gene to favor high 
levels of expression, as well as unique restriction sites for future subcloning and 
mutagenesis experiments (15). The gene was subcloned into the pUC19 expression 
vector and the recombinant protein was determined to be approximately 10% of the 
soluble protein in the E.coli strain TB-1 (ara, A(lac-pro), strA, thi, (()80d/acXAM15, r-, 
m+) (15).
Recombinant DNA:
Polymerase Chain Reaction (PCR): All polymerase chain reactions were 
performed using a Stratagene Robocycler with a hot top. All reactions included IX 
Thermopol Buffer (10 mM KCl, 10 mM (NH4)2S04, 20 mM Tris-HCl pH 8.8 at 25°C, 2
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mM MgS04,0.1% Triton X-100 supplied by New England Biolabs), 1 pmol of each 
primer, 2 mM additional MgS04, 1 mM dNTP mixture and 2 units of Deep Vent 
Polymerase in a total volume of 50 pL. Each cycle consisted of a 30 second melting 
stage at 95 °C, one minute annealing stage at various annealing temperatures followed by 
a 30 second elongation stage at 72°C. Each PCR cycled thirty times.
DNA Visualization: DNA was analyzed on 1% w/v agarose gels. Agarose gel 
electrophoresis was performed for approximately 1.5 hours at 80 V in modified TAE 
buffer, stained in an ethidium bromide solution (10 mg/mL) for 10 minutes and destained 
in deionized water for 10 minutes. DNA was visualized on an UV transilluminator, and 
results were recorded with a Polaroid camera.
DNA Purification: DNA was purified agarose gel using Millipore DNA extraction 
l^its. A small slice of an agarose gel with the desired size DNA was cut from the gel and 
inserted into the Millipore filter. The filter was spun at 5000 g for 10 minutes to separate 
the DNA from the agarose. Qiagen kits were also used to purify DNA following the 
manufacturer’s instructions. The Qiagen Minelute system was used to separate large 
pieces of DNA, such as linear vector, from small fragments less than 100 bp. Qiagen 
PCR-Prep kits were used to purify small fragments of approximately 500 bp. Qiagen 
Miniprep kits were used to purify plasmid DNA from E. coli.
Restriction Digestions:. Digestions were performed in IX buffer supplied by 
neb for the enzyme (or the buffer suggested by NEB for double digestions) at the 
recommended temperature for two hours. Bovine serum albumin (BSA) was added to 
reactions as recommended by NEB. The amount of enzyme used per reaction was equal 
to the number of units in IpL of undiluted stock.
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Ligation: Ligation reactions consisted of IX ligase buffer (50 mM Tris-HCl, 10 
mM MgCh, 10 mM DTT, 1 mM ATP, 50 Hg/ml BSA, pH 7.8 at 25°C supplied by NEB), 
approximately 50 to 200ng vector, an equivalent molar amount of insert and 400 units of 
T4 DNA ligase. Reactions were incubated at 16°C for 16 to 24 hours. The ligase was 
then heat killed at 65°C for 10 minutes to prepare the reaction for electroporation.
Electroporation: A Biorad Gene Pulser II was used with 1 mm cuvettes, using 
settings for resistance of 200 ohms, a potential of 1.25 kV/mm, and a capacitance of 25 
pF. Approximately 2 to 4 pL of heat killed ligation reaction was added to 100 pL 
electrocompetent cells ( E.coli strain XLl-Blue unless otherwise noted). Immediately 
after the electric discharge, 1 mL of SOC medium (Luria Bertani medium + 200 mM Mg 
2+ and KX) mM glucose) was added to the cuvette. The cells were incubated for one 
hour at 37°C, then plated on 50 pg/mL ampicillin LB (Luria Bertani medium + agar) agar 
plates and grown at 37°C overnight.
Construction of the pMAL-HGL16 expression plasmid: HGL16 was PCR 
amplified from the tanL2 tandem swMb gene construct, using the PCR program 
mentioned above. The resulting dsDNA fragment was gel-purified, restricted with BamHI 
and Pstl, and ligated into pMAL (NEB). The ligated plasmid was transformed into E. coli 
strain XLlBlue. Transformed cells were grown on LB/ampicillin (50 pg/mL) agar plates 
overnight, and candidate clones were screened by restriction analysis and a PCR-based 
clone check with the bottom PCR primer and a pMAL-specific sequencing primer to 
confirm the presence of the permutein gene. The MBP-HGL16 gene sequence was 
confirmed by dideoxy sequencing (SAC-25).
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Table 1: Maltose-Binding Protein Fusion Primers
MBP-HGL16 PstI primer MBP-HGL16 BamHI primer
ACGAGAACTGCAGTGATTATGGAT GAGCGCGGATCCGGTGACTTCGGTGC
GTCTAGAATGCAGAA TGACGCTCAG
PCR Clone Check: Colonies were picked from the transformation plates, touched 
to a gridded plate, and then swirled in 50 uL of doubly-distilled water in 0.5 mL 
Eppendorf tubes. 50 uL of 1 M NaOH was added, and the cell solution was incubated at 
80° C for 10 minutes to lyse the cells. 10 uL of this cell solution was added to the PCR 
mixture as described above and cycled through the normal run. Primers used include 
pMAL sequencing primer (for MBP-HGL16) with the HGL16 BamHI bottom primer, or 
the pTrc99a sequencing primer with the appropriate, opposite HGL16 primer. One other 
method, useful for plates with only one or two colonies, involves purifying plasmid from 
overnight cultures of specific colonies. The grid plate with numbered colonies can then 
be used to make seed stocks if they produce an amplified gene in the PCR.
Creating the H64F-HGL16 gene: Site-directed mutagenesis was performed on an 
HGL16 template in pTrc-99a, using a Quikchange II Mutagenesis kit (Stratagene). The 
H64F mutation was confirmed by dideoxy sequencing (SAC-45/46). Strain: XLlBlue 
Gold.
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Table 2: H64F-HGL16 mutagenesis primers
HGL16 H64F mutagenic coding primer HGL16 H64F mutagenic nonocoding primer
gaagatctgaaaaaattcggtgt
taccgtcttaactgcc
GGCAGTATTCACGGTAACACCGAATTTT
TTCAGATCTTC
Subcloning HGL16 into the pET17b plasmid: Moving HGL16 into pET17b was 
attempted multiple times but all were unsuccessful. PCR, using pTrc99a-HGL16 as a 
template, with conditions described above, was successful at amplifying HGL16 gene 
with the engineered Ndel and Kpnl restriction sites; the gene was gel-purified.
Table 3: Primers for moving HGL16 into pET17b
pET17b-HGL16 Ndel primer pET17b-HGL16 Kpnl primer
gggattaccatatgggtgacttg
GGTGTTGACGCT
AACGGGTACCCATCATGGATGTCTAGA
ATGCAGAACAT
Protein Preparation:
Protein Expression: All permuteins were expressed in 1 L bacterial cultures in 2.8 
L Fembach flasks at 37 °C with shaking of about 200 revolutions/min in a Lab Line 
Incubator-Shaker. The E. coli were grown in LB broth with 50 mg/mL ampicillin until 
niid log phase (OD6oo = 0.5-0.7) then induced with 0.1 mM isopropylthiogalactoside 
(IPTG). The cultures were then allowed to grow for an additional 4-5 hours then 
harvested by centrifugation (4000 g for 10 minutes).
Protein Purification: The harvested cells were resuspended in approximately 30 
niL lysis buffer (50 mM Tris-HCl, 17 mM NaCl pH 8.5) then lysed by sonication, using a
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Branson Instruments, Inc. Sonifier 450 at power level 6, 50% power. Each sample was 
allowed to sonicate for I minute on, I minute off three times or until lysis was complete. 
The samples were then centrifuged at 21,000 g for 20 minutes and the supernatant 
retained. The pH of the lysate was adjusted to 8.0-8.5 with 1 M NaOH, and zinc acetate 
was added to a final concentration of 1 mM. The lysate was centrifuged at 40,000 g for 
20 minutes, then filtered through a 0.45 pm filter. Due to the uncommonly high number 
of surface-exposed histidines in Mb, the filtered lysate was then loaded on a prepared 
zinc immobilized metal ion affinity column (IMAC) consisting of Amersham Pharmacia 
Biotech Chelating Sepharose Fast Flow resin. The column was washed with buffer and 
then the protein was eluted with ethylenediaminetetraacetate (EDTA). The partially 
purified permutein proteins were concentrated in Amicon Centricon concentrators (YM- 
10), molecular weight cut off of 10,000 Da, by centrifuging at 5000 g for half hour 
increments until the total volume was approximately 300 pL (0.5 mM myoglobin). 
Partially purified wild-type myoglobin was buffer exchanged into 20 mM Tris-HCl pH 
8.5 using an Amicon Centriprep-10, molecular weight cut off of 10,000 Da, at 3000 g (4 
spins at 30 minutes each). The wild-type myoglobin was then concentrated using a 
Centricon to approximately 500 pL (1.0 mM myoglobin). After IMAC, permuteins were 
purified by size-exclusion chromatography using an Amersham Pharmacia Biotech 
Superdex 75 HR 10/30 size exclusion column (HPSEC) attached to a Varian ProStar 
high-pressure liquid chromatography (HPLC). The samples were spun at 14,000 g for 15 
minutes, then filtered through a 0.2 pm filter. Approximately 500 pL of the prepared 
protein was then injected on the column. The buffer was 20 mM Tris-HCl, 150 mM 
NaCl pH 8.0 and was pumped at a rate of 0.5 miymin. Absorbance at 280 nm was
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monitored and fractions were collected corresponding to peaks at this absorbance as well 
as peaks at A409. The purity of each lot of wild-type myoglobin was assessed using the 
HPSEC column. All proteins were concentrated again in Centricons to a final 
concentration of approximately 0.5 mM myoglobin. Protein concentration was 
determined using £418 = 128 mM’**cm** and C280 = 15.2 mM **cm *. MBP-HGL16, 
H64F-HGL16 and apoMb were determined to be more than 95% homogenous by SDS- 
PAGE and/or analytical reverse phase HPLC.
SDS-PAGE: Proteins were analyzed using sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE). All gels consisted of 10% w/v acrylamide (pH 8.8). 
Electrophoresis buffer was 25 mM Tris, 250 mM glycine (pH 8.3) and 0.1% w/v SDS. 
Gel loading buffer used was 50 mM Tris-HCl pH 6.8, 100 mM DTT, 2% w/v SDS,
0.25% w/v bromophenol blue and 10% v/v glycerol. Gels were run for approximately 
one hour at 50 mA then were stained in Coomassie Brilliant Blue stain (50% v/v 
methanol, 10% v/v acetic acid, 0.1% w/v Coomassie Brilliant Blue R250) and destained 
in a 1:3:4 acetic acid:methanol:water mixture. SDS-PAGE gels were stored in a 15% w/v 
acetic acid solution. Biorad Precision Plus Molecular Weight Standards acted as markers 
in all gels.
Cleavage ofMBP-HGL16. Cleavage studies were performed at 37° C, using 
chymotrypsin (Sigma) and Genenase (NEB), 100 pg/A, at 4 k, in the SEC buffer in which 
protein was eluted. Reaction volumes were often 200 A, of 4 pg/A. fusion protein + 4 A, of 
enzyme. Time point samples were analyzed via SDS-PAGE, Western Blot and analytical 
SEC runs. Western Blots used rabbit antiMb primary antibodies and goat antirabbit
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secondary antibodies plus a horseradish peroxidase conjugated developing agent 
(Biorad).
Apomyoglobin Expression and Purification. pET17b with wt swMb was donated 
by H. Jane Dyson, and expression followed Dyson lab protocols previously described, 
with rich medium rather than M9 minimal medium (13). Some changes were made: 
Inclusion bodies were solubilized using 3M GdnHCl, dialyzed overnight into 20mM Tris 
pH 7.5, concentrated as above, and purified by HPSEC in lOmM Tris pH 8.5 buffer. 
SDS-PAGE analysis showed 95% purity. Wt swMb in pET17b was confirmed by 
dideoxy sequencing (SAC-43/51). Analytical HPLC was performed on a Vydec C4 
Reverse-phase column, with a gradient of buffer A (0.1% v/v trifluoroacetic acid in 
water) to buffer B (80% v/v acetonitrile, 0.1% v/v trifluoroacetic acid) over 30 minutes, 
starting at 30% B, 70% A and going to 100% B at 30 minutes. ApoMb eluted at 11.9 
minutes and holoMb at 12.2 minutes.
Urea Denaturation: All reactions occurred at room temperature (25°C) in 10 mM 
potassium phosphate, 100 mM KCl buffer pH 8.5. New urea solutions were made for 
each denaturation, and the concentration of the urea solutions (approximately 10 M) was 
determined using refractive index'. A determined amount of buffer, sterile water and 10 
M urea were mixed well and met-Mb with oxidized heme was added to a final volume of 
400 pL and a final heme concentration of approximately 5 pM. Samples equilibrated 
overnight. Met-B (oxidized heme) was produced by adding 1.1 molar equivalents of 
0.015M potassium ferric cyanide to the stock protein solution. Circular dichroism (CD)
' [Urea] (M) = 117.66*AN + 29.753*AN^ + 185.56*AN^
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spectroscopy at 222 nm and UV-Vis spectroscopy at 409 nm were used to observe the 
unfolding of protein.
pH Denaturation Studies: pH denaturations were performed as described above 
for chemical denaturations. Apo-Mb was used in concentrations of ~ 20 pM.. Buffer 
conditions included a series of 100 mM KHPO4, KH2PO4, glycine and EDTA buffers at 
pH between 1.85 and 6.0; after diluting buffers 10 fold into the spectral sample, samples 
were incubated overnight and the pH was checked again before each CD spectrum was 
taken.
Analysis of Data: Data analysis was carried using Microcal Origin 5.0. Curves 
describing a two-state transition were fit to the data. In the two-state model, there are no 
intermediate structures in the unfolding process. The folded myoglobin unfolds to 
denatured myoglobin and free heme (N D + heme).
Origin was programmed with a non-linear curve fitting function that allowed a 
dependence of the native and denatured state absorbances on denaturant concentration. 
The function is as follows (19):
(an-i-bn*x+((ad+bd*x)*exp(-((bb+mm*x)/RR*TT))))))/(exp(-((bb+mm*x)/(RR*TT)))+l)
Variables:
an = native state absorbance (An)
bn = dependence of native state absorbance on denaturant concentration 
ad = denatured state absorbance (Ad)
bd = dependence of denatured state absorbance on denaturant concentration
bb = AG®h2o (kcal/mol)
mm = slope of transition (m) (kcal/(mol*M))
Constants:
RR = 0.0019872 (kcal/(mol*K))
TT = 298.15 (K)
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This function calculates best fit curves by optimizing an, bn, ad and bd, bb and mm. The 
midpoint of the transition (Cm) was determined by taking the derivative of the curve fit.
Normalization of data for figure 15 involved subtracting the absorbance signal in 
8 M urea from each preceding data point, then dividing each data point by the absorbance 
signal in 0 M urea, to give the fraction folded. Fn = (An - AgMurea) / AoMurea- This equation 
assumes that the protein is fully folded in native conditions (0 M urea) and fully unfolded 
in 8 M urea.
Results:
MBP-HGL16 Expression
The fusion protein MBP-HGL16 was expressible, with higher yield and longer 
post-induction time (PI) —^time after addition of IPTG—than observed for direct 
expression of HGL16. The fusion is maximally expressed at seven hours PI, as verified 
by Western Blot (data not shown due to poor resolution). The fusion protein was purified 
from E. coli in soluble form as described above; post-IMAC samples are shown in Figure 
3 as a check of fusion protein’s approximate molecular weight of ~61 kDa. Following 
purification, MBP-HGL16 yields were calculated at 1.5 mg/L, based upon heme 
absorbance at 418 nm—this yield was based upon four separate experiments. This yield 
is five times higher than the current HGL16 yields of 0.3 mg/L (Table 4).
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Table 4: Yields of free HGL16 compared to HGL16 
fused to MBP, based upon heme absorbance (mg of protein per 
liter of cell culture).
Free HGL16 MBP-HGL16
0.30 mg/L 1.5 mg/L
60 kDa
I
I Figure 3: SDS-PAGE 
I showing two representative 
I samples of Coomassie Blue- 
I stained MBP-HGL16 in the 
I right two lanes. Both are 
I post-IMAC purified samples.
MBP-HGL16 Cleavage Optimization
Though the MBP-HGL16 fusion protein can be cleaved with proteolytic enzymes, 
cleavage proved to be inefficient. NEB designed the pMAL plasmid so that the linker 
between MBP and the target protein would be specifically cleaved by Genenase, a 
protease or protein-cleaving enzyme. Genenase did not cleave the fusion protein, while 
chymotrypsin—a less specific protease—proved able to cleave the fusion protein (Figure 
4). Free HGL16 released from the fusion protein made up -20% of total permuted Mb
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present, after cleavage was optimized—from 1.5 mg of HGL16 fusion, 0.30 mg of free 
HGL16 were liberated. After purification of the products of the cleavage reactions by 
SEC, too little free HGL16 was collected to make large-scale cleavage/purification more 
efficient than the direct expression and two column purification of HGL16 procedure 
already in place.
Figure 4: SDS-PAGE gel, stained 
with Coomasie Blue, showing cleavage 
reactions of MBP-HGL16 with 
chymotrypsin or genenase at 37° C. 
Lanes: (1) 1 hr, genenase, (2) 2 hrs, 
genenase, (3) 3 hrs, genenase, (4)-(7) 1-4 
hrs with chymotrypsin. A: MBP- 
HGL16 fusion, B: free MBP, C: 
chymotrypsin/ genenase, D: free HGL16
MBP-HGL16 Denaturation
Urea denaturation of the holo-fusion construct, monitored via absorbance at 409 
nm (where the oxidized heme absorbs), shows the HGL16 portion of the fusion to be less 
stable than free HGL16 (Figure 5a). Curve-fitting analysis using the method of Santoro 
and Bolen (19) gave AG°h20 = 3.5 ±1.7 kcal/mol. Cm = 3 M, compared to AG°h2o = 7.2 
kcal/mol. Cm = 4.2 M for holo HGL16 (Figure 5b). Large errors were generated because 
few data points constrain the pre- and post-transition baselines. More data, though, 
require more protein, yet low protein recovery means fewer data points and more error.
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This is the very problem we are trying to solve. Without more data in the transitions, 
these results remain preliminary.
Figure 5: (A) Urea denaturation of MBP-HGL16. Monitored at 409 nm, with calculated 
curve-fit (19). (10 mM potassium phosphate, 100 mM potassium chloride pH 8.5). Performed at 
25® C. (B) Urea denaturation curves of HGL16 (diamonds and triangles) and wt swMb (circles 
and squares), see ref 3.
Apomyoglobin Purification and Yield
As reported previously (13), expression of wt swMb in the plasmid pET17b 
yielded large amounts of relatively pure, insoluble inclusion bodies of apoMb. At five 
hours PI, a large overexpression band corresponding to the MW of Mb was seen in crude 
cell lysate (lane one. Figure 6); further, a similar band was seen in the soluble cell lysate 
(lane four. Figure 6), suggesting soluble myoglobin present. After purifying the 
resobulized, dialyzed inclusion bodies with SEC, >95% purity was achieved for apoMb 
(Figure 7). The circular dichroism (CD) spectrum of the purified apoMb showed the 
expected signal characteristic of an alpha-helical protein—minima at 208 and 222 nm 
(Figure 8). Yields of pure apoMb were much higher than our group historically obtained
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using the heme extraction (with methyl ethyl ketone) method (17), which requires holo- 
Mb as starting material. From 20 mg of holo wt swMb, we would obtain ~5 mgs of 
purified apo—a recovery of only 25% of sample. Much of the loss is due to protein 
aggregation. Given past yields of holo wt swMb of 5-6 mg/L, this percentage loss 
corresponds to 1.25 mg of pure apo—not quite enough for a single denaturation 
experiment, let alone NMR studies. In the case of permuted myoglobins with low yields, 
this loss of protein represents a major obstacle to the subsequent characterization of the 
protein. With the inclusion body purification protocol, yields of pure apoMb approach 20 
mg/L (Table 5).
Table 5 : Yields of wt apo swMb from holo + heme extraction or direct 
inclusion body expression (mg of protein per liter of cell culture, as calculated 
from absorbance at 280 nm).
Holo + heme extraction Direct expression of apoMb
1.25 mg/L 20 mg/L
Figure 6l SDS-PAGE gel stained with 
Coomassie Blue, showing 
overexpression bands, in crude cell 
lysate for apoMb expression. Lanes: (1) 
5 hours PI, (2) one hour PI, (3) zero 
hours PI. (4) soluble cell fraction, 5 hrPI
Figure 7: SDS-PAGE gel stained 
with Coomassie Blue, showing 
purification of inclusion body apoMb. 
Lanes: (1) holo wt control, (2) crude 
inclusion body, (3) SEC- pure apoMb.
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Figure 8: CD spectrum of 20 pM apoMb (20 mM Tris pH 
8.5) purified from inclusion bodies.
HPLC Analysis of Protein Purity
Reverse-phase HPLC experiments show that our apoMb (lane 3, Figure 7) elutes 
at 37% acetonitrile and comprises >90% of the sample, based upon area under all peaks 
(91 AU sec for apoMb / 98 AU sec total) (Figure 9a). Our purified apoMb has an elution 
profile very similar to that of SEC-pure wt holoMb grown and harvested by conventional 
methods (Figure 9b), yet appears more pure than wt isolated by our 2-column procedure.
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(a) (b)
Figure 9: Reverse-phase HPLC chromatogram of directly expressed and purified apoMb 
(a) versus wt holoMb (b) conventionally expressed and purified, (a) has greater than 90% 
purity.
Apomyoglobin urea and pH Denaturations
To ensure our purification protocol was sound and useful for future comparisons 
of apo-HGL16 and apo-H64F-HGL16, we performed both urea and pH denaturations of 
the apoMb purified from inclusion bodies, monitoring via CD at 222 nm. Our urea 
denaturation approximated the results of other labs: similar CmS and m-values (13) 
(Figure 10a). However, our pH denaturations, performed on apoMb confirmed to be pure 
(Figure 9), produced a large amount of scatter. No intermediate was verified. A 
representative pH-induced denaturation is shown below (Figure 10b); though a pre­
transition baseline is discernible, data at pH near the intermediate are highly scattered, 
and the post-transition baseline needs more data points to constrain it.
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pH
FigurelO: CD Urea and pH denaturations of apo wt swMb. (a) urea denaturation with calculated curve 
fit (18) (10 mM K phosphate pH 8.5); (b) pH denaturation. Both are monitored at 222 nm. Denaturations 
were performed at 25 C.
Subcloning HGL16 into pETlVb plasmid was unsuccessful
No constructs have been made of HGL16 in pET17b successfully. Double-digests 
of the pET17b plasmid seemed to be the obstacle: after ligation of doubly-digested gene 
and vector which has been doubly-digested and gel-purified, colonies that grew after 
transformation into BL21(DE3) contained only wt swMb as gene insert. Such results 
suggest that singly-digested plasmid is carried through the gel purification and is 
religated in the ligation. This may be the result of an enzyme not cutting efficiently or too 
liberal of cutting when removing bands from agarose gel after double-digestion and gel- 
purification.
H64F-HGL16 Purification and Preliminary Yields
H64F-HGL16 is expressible from the plasmid pTrc99a; at seven hours post­
induction, one liter of cell culture yields red protein after purification, with the 
characteristic Soret absorbance for the heme at 418 nm. [Seven hours PI was somewhat
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arbitrarily defined (and has not been optimized): one liter harvested at four hours PI 
yielded very little protein, so seven hours PI was used, and more protein was recovered.] 
Protein was >95% pure after IMAC and SEC purification (Figure 12). A slightly-higher 
MW contaminant (SEC fraction 1) was separated from pure H64F-HGL16 after SEC 
(Figures 11 and 12). Preliminary yield, averaged from a six liter purification, was ~ 0.21 
mg/L (yields of the HGL16 permuted myoglobin currently average 0.30 mg/L), as 
calculated from the absorbance of the heme at 418 nm.
However, X max for the Soret peak shifted from 418 nm to 425 nm (for the 
reduced form of the heme); further, X max for the oxidized form of the heme shifted from 
409 nm to 395 nm, at pH 7.5 in the absence of denaturant (Figure 13). When 2.0 M urea 
was added, X max for oxidized H64F-HGL16 shifted back to 409 from 395 nm. 
Consequently, denaturation experiments may contain artifacts when monitoring 409 nm 
on a UVA^is spectrophotometer. As most previous studies have worked exclusively with 
directly expressed apo-H64F mutants, changes in X max and the extinction coefficient 
have not been published, so, to ensure accuracy in calculating concentrations, absorbance 
of the tryptophan residues at 280 nm should be used to quantify expression yields of the 
mutant H64F-HGL16 (Table 6).
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purification of H64F-HGL16. Lane 1: MW 
Marker, (2) HGL16 control, (3) SEC fraction 1, 
(4) SEC fraction 2, H64F-HGL16
Figure 13: Absorbance traces for H64F-HGL16 
with reduced heme (solid line), oxidized (dashed 
line), oxidized & 4 M GdnHCl (dotted line)
Table 6: Current yield for HGL16 compared to H64F-HGL16 (mg protein/ liter 
of cell culture) based upon heme absorbance at 418 nm for HGL16 and H64F-HGL16, 
and tryptophan absorbance at 280 nm for H64F-HGL16.
HGL16 (418) H64F-HGL16 (418) H64F-HGL16 (280)
0.30 mg/L 0.21 mg/L 0.37 mg/L
Holo H64F-HGL16 Preliminary Urea Denaturation
Preliminary chemical denaturation of the holo-H64F-HGL16, monitored at 409 
nm, was performed to estimate the mutant’s stability relative to HGL16. The unfolding 
curve lacks a pre-transition baseline (Figure 14). Given the observed behavior of X max 
in various environments, we might conclude that UV/Vis spectroscopy, monitoring
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changes in the heme’s absorbance, does not give a true picture of the unfolding of H64F- 
HGL16 upon addition of chemical denaturants. CD denaturations, monitoring secondary 
structure rather than the tertiary environment surrounding the heme pocket, should give 
more reliable information about the urea-induced unfolding of H64F-HGL16.
0.35
0.30
0.25
o> o
< 0.20
0.15
0.10
Figure 14: UVA^is denaturation of 5 ^M H64F-HGL16 
lacking a pre-transition baseline. Monitored at 409 nm.
Preliminary CD denaturation and spectrum of H64F-HGL16
As expected, the CD spectrum of H64F-HGL16 shows features of an alpha- 
helical protein (Figure 15a), with minima at 208 and 222 nm, similar to the CD spectrum 
of holo HGL16 (Figure 15b).
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Figure 15: (a) CD spectrum of 6.5 pM holo H64F-HGL16 (10 mM potassium 
phosphate, 100 mM potassium chloride pH 8.5), (b) CD spectrum of 5 pM holo HGL16 in 
O M and 8 M urea, 100 mM potassium phosphate pH 7.0 (Jennifer (White) Keeffe)
In contrast to wt swMb and wt H64F swMb apo-proteins, the urea denaturation 
profile of the holo permuted mutant H64F-HGL16, monitored by CD, shows a non- 
cooperative unfolding transition similar to the UV-Vis-monitored denaturation in Figure 
12 (Figure 16a). No pre- or post-transition baseline is seen. This curve is similar to that 
obtained for apo-HGL16 (Figure 16b). This suggests that the H64F mutation does not 
exert the same stabilizing effect in the permutein HGL16 that is observed for wt swMb. 
UV-Vis- and CD-monitored urea denaturation curves for H64F-HGL16 superimpose, 
suggesting that the UVA^is data are not artifactual (Figure 17).
Casey Kulla, 27
Increasing Expression Yields of Circularly-Permuted Myoglobins
I • I > I » I » I
E
ô
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Figure 16: (a) Urea denaturation of 6.5 ^iM holo H64F-HGL16 (10 mM potassium 
phosphate, 100 mM potassium chloride pH 8.5), monitored by CD at 222 nm. (b) denaturation 
of apoHGL16 with curve fit (18), monitored by CD at 222 nm. Data for (b) collected by Jason 
Horng, SUNY Stony Brook.
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Discussion:
Our results show that of the three methods of increasing the yields of permuted 
Mb, low efficiency in cleavage of MBP-HGL16 makes the fusion system not useful, the 
inclusion body purification protocol shows much promise, while the H64F mutation in 
HGL16 may not increase yields but will help us learn how HGL16 compares to wt 
swMb.
We see that MBP-HGL16 is expressed at higher levels than free HGL16, with 
yields 5 times higher: 1.5 mg/L vs. 0.30 mg/L (Table 4). Given such a large increase, it 
would be tempting to think this model system would be at least one potential method for 
supplying our group with sufficient quantities of easily-purified protein; however, we 
found that Genenase, which the fusion system is designed to employ (Figure 18), did not 
cleave the fusion protein.
Genenase Cleavage Site
Figure 18: Diagram of MBP-HGL16 fusion protein with Genenase-specific cleavage site.
Little cleavage product was seen at any time point or incubation temperature (Figure 4). 
Others have had success with chymotrypsin as the protease (Lisa Gentile, personal 
communication), therefore we experimented with it. Chymotrypsin did cleave the fusion, 
and after optimizing cleavage, -20% efficiency was observed; for example, 1.5 mg of 
HGL16 fusion were incubated and only 300 pg of free HGL16 were recovered. Given 
that recovery required cleavage at 37° C for two hours and purification with SEC, this
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percentage recovery was not sufficient to warrant using MBP fusions as expression 
systems, because isolated yields of pure HGL16 would be lower than those recovered 
through direct expression of HGL16. It is possible that HGL16, as with other fusion 
partners, is fitting snugly into a binding cleft in MBP, protecting it from proteolysis (8), 
One recent paper reports, however, that denaturing the fusion in guanidine before 
cleavage results in higher cleavage efficiency (9); thus, higher efficiency in our system 
might be obtained under denaturing conditions.
Preliminary urea denaturation of the fusion shows that when fused to MBP, 
HGL16 is destabilized; it may be that fusion to the C-terminus locally destabilizes the H 
helix. As free MBP has stability comparable to that of holo wt swMb (Cm ~ 8 M urea), 
MBP is not unfolding at the urea concentrations used in experiments shown in Figure 3 
(10). So, do we have an example of stability and expression yield not being correlated? 
Though MBP-HGL16 expresses at higher yields than free HGL16, it is likely that the 
efficient overexpression and high stability of MBP itself drives the higher level of 
expression of an apparently destabilized fusion partner HGL16.
Expression of Mb using the T7 promoter of the pET17b plasmid, isolation, 
resolubilization and dialysis of inclusion bodies, and purification with SEC is an effective 
way of producing apoMb, with >95% purity. Yields of wt apoMb per liter are up to 20 
times higher than those obtained using our previous method of expressing holo Mb and 
extracting the heme. Further, at eight hours post-induction, 13 mg of holoMb per liter of 
cell culture are found in the soluble cell lysate (measured by Soret absorbance at 418 
nm). Direct expression of apoMb avoids the steps of unfolding, heme extraction, and 
refolding which account for large losses of protein. Purification schemes based on
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inclusion body formation by E. coli typically yield very pure protein in relatively few 
steps.
We have made some modifications to the Dyson protocol (13), and with these 
modifications, we must ensure that our protein is equivalent to that obtained by the 
traditional two-column procedure for holo wt, i.e. high enough purity. With our 
modifications, protein seems equivalent to that obtained by their lab (judging by purity on 
SDS-PAGE analytical gels, analytical SEC, and urea denaturation). Our reverse-phase 
HPLC data show good proof that apoMb is >95% pure after purification by SEC, 
possibly more pure than wt holoMb—although long-term storage of holoMb results in 
degradation. Realistically, our apoMb is as pure as wt holoMb controls. However, our 
attempts to replicate other labs’ pH denaturations of apoMb were not successful; a great 
deal of scatter is seen in the data points around the pH intermediate range, though pre- 
and post-transition baselines are acceptable. This may indicate a difference in the protein 
sample introduced by the modification of Dyson’s protocol, but given our evidence of 
apoMb purity, the denaturations themselves may simply need to be performed again.
The hope is that direct expression of apo permuted Mbs will allow for extensive 
characterization of the HGL16 apoprotein. Such characterization would take advantage of 
the large body of knowledge about apoMb, including stability of various mutants, folding 
pathways, binding kinetics, and intermediates (3, 11-16). As part of our analysis of how 
topological mutation affects Mb folding, stability and function, we hope to explore the 
pH 4.2 intermediate, asking whether HGL16 shows such an intermediate. The presence 
of the intermediate would indicate similarities in structure and interacting helices 
compared to wt, and how structured such an intermediate is relative to folded and
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unfolded forms of both HGL16 and wt swMb. Once HGL16 is cloned into the pET17b 
plasmid, work can begin on directly comparing our permutein to wt.
Using absorbance at 280 nm, given the shift in X max for the heme in H64F- 
HGL16, we see that expression yields have increased slightly—likely, yields of the 
permuted mutant are equivalent to yields of pure HGL16. While 0.37 mg of protein lacks 
luster, such yields are exciting: this is evidence that we can perform site-directed 
mutagenesis on HGL16, create point mutants, purify them, and compare them to HGL16 
and similar wild-type point mutants. While yield may not increase, stability, function or 
folding pathway may change. We would like to create more point mutants, such as those 
with altered autooxidation rates (rate at which heme goes from reduced to oxidized), 
increased CO affinity, to observe how topological mutation affects point mutants known 
to have specific effects on the function of Mb. We might make an HGL16 double mutant 
H64Y/V68F to observe changes in heme dissociation rates (20).
H64F, the most stable point mutation in swMb (13), should increase yields of 
HGL16 dramatically if (a) stability and expression yields are correlated for the permuted 
globin as they are for the wt Mb (5) and if (b) this mutation increases the stability of 
HGL16. While we see no evidence for large increases in yield for the permuted mutant, it 
is not necessarily the case that (a) or (b) above are false. The correlation of stability and 
expression yield may remain true, as H64F may not change the expression yields because 
it does not change the stability of HGL16. No change in stability, however, would be 
quite strange given the precedent in wt and the dramatic change in amino acid character 
by substitution of Phe for His. His prefers to be solvated, while Phe prefers a 
hydrophobic environment; as the interior of the heme pocket is relatively hydrophobic.
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introducing a Phe in place of His into this region should be entropically and enthalpically 
favorable. Chemical denaturation studies should illuminate the differences between 
HGL16 and H64F-HGL16.
With a unique absorbance for both oxidized and reduced heme (395 and 425, 
versus 409 and 418 nm), H64F-HGL16 has a changed environment near the heme, 
evidence that the Phe introduction has some effect on the protein. The oxidized form of 
the heme, with an initial absorbance at 395 nm, shifts back to the typical oxidized heme 
absorbance at 409 nm upon addition of 2.0 M urea. Such behavior might complicate 
denaturations monitoring 409 nm; pre-transition baselines may be fouled by the shifting 
X max. When urea denaturation of holo permuted mutant H64F-HGL16 is performed and 
monitored via change in absorbance at 409 nm, no pre-transition baseline is seen; as well, 
the denaturation curve follows neither sigmoidal nor exponential decay behavior. Curve- 
fitting proves unreliable, so AG°h20 cannot be calculated with any confidence. Since the 
protein is unfolding in the presence of urea, to get a different view of the mutant protein’s 
behavior from that of UV-Vis-monitored changes in heme absorbance, we can monitor 
changes in secondary structure via CD spectroscopy.
Figure 16a shows another non-sigmoidal, non-cooperative decay protein 
unfolding as signal and secondary structure diminish. Again, no pre-transition baseline is 
present, making Santoro and Bolen curve-fitting prone to large errors in determination of 
AG°h20- In fact, these two anomalous curves—which monitor different structural 
characteristics—are superimposable (Figure 17).
Assuming both curves are either the product of experimental error or some 
experimental artifact would make interpretation of the data simple: the data are
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completely flawed and must be thrown out; however, both curves remain similarly 
anomalous, rather than singularly so. If we are observing unfolding upon the addition of 
any amount of denaturant, then perhaps H64F-HGL16 is severely destabilized compared 
to HGL16, just as apo-HGL16 is destabilized relative to holo-HGL16. Comparing Figure 
15 to Figure 14b, we see similar curves for apo-HGL16 and holo-H64F-HGL16; this 
suggests that the H64F mutation does not exert the same stabilizing effect in the 
permutein HGL16 that is observed for wt swMb, or perhaps the mutation is stabilizing 
intermediates relative to the native state.
Our original intention was to transfer the permuted mutant to the pET17b 
plasmid, in order to express apo-H64F-HGL16, purify it, and characterize it under both 
urea and pH denaturing conditions. Given our difficulty subcloning HGL16 into the 
pET17b plasmid, we were unable to get HGL16 in pET17b as the template for our 
mutagenesis. Attempts to subclone H64F-HGL16 directly into the pET17b plasmid are 
ongoing.
Conclusions:
Our research has shown, first, that the MBP fusion system, while increasing 
expression yields of our Mb, destabilizes the fused protein and is not efficiently cleaved. 
Hence, it is not useful for the purification of HGL16 permuted myoglobins. Second, the 
direct expression of apoMb and purification of inclusion bodies can be modified for use 
in our lab. Further, with high yields and one column purification step, it holds much 
promise for producing enough permuted protein to continue characterizing HGL16, such
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as by NMR. Third, mutating permuted HGL16 by substituting Phe for His at residue 64 
(115 in HGL16) produces yields similar to wt HGL16. Shifts in heme absorbance and 
non-cooperative denaturation curves suggest that the mutation does not significantly 
stabilize the permutein, or stabilizes intermediate states.
In short, increased yields of the permuted myoglobin HGL16 were not realized 
with all three methods, but they do reveal more about what occurs when a topological 
mutation is introduced into a well-characterized globin protein such as sperm whale 
myoglobin: fusing a large protein domain to the H-helix appears to destabilize HGL16, 
while mutating His64 to Phe affects the heme environment and appears to destabilize 
HGL16, opposite of its effect on wt swMb. And they raise many more questions: what 
happens to the structure of the heme pocket when mutations are made in HGL16? How is 
the folding pathway of swMb affected by the topological mutation HGL16, and how is 
the folding pathway of HGL16 affected by the wt-stabilizing point mutation H64F? 
Before rational protein design and engineering can be effective, these questions must be 
answered.
As Chu et al. note, placing point mutations in an engineered protein may populate 
the native, functional state of a protein relative to a partially-unfolded form, making 
biotherapeutics more efficacious, biocompatible and stable (21). With our apoMb 
inclusion body protocol and the H64F and future point mutants of HGL16, we will add 
more knowledge of engineered protein systems to the collective body, furthering rational 
drug design and the understanding of how proteins—arguably the most complex 
biological molecules—fold into functional forms.
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